0.0005
0.0000
(0.00%)
As of April 3 at 4:00:00 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Mike Qingkun Wang | CEO, President, CFO, Secretary & Chairman of the Board | 54k | -- | 1955 |
| Mr. Qinghua Chen CPA | Chief Financial Officer | 11.08k | -- | 1963 |
| Mr. David Liu | Chief Operating Officer | -- | -- | -- |
| David Tsai | Chief Scientist | -- | -- | -- |
America Great Health
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 5
Description
America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and nutritional dietary supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, California.
Corporate Governance
America Great Health’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Related Tickers
OKYO OKYO Pharma Limited
1.1800
-2.48%
TLX Telix Pharmaceuticals Limited
14.26
-11.70%
ARGX argenx SE
570.03
-3.40%
UTHR United Therapeutics Corporation
301.23
-2.00%
MDGL Madrigal Pharmaceuticals, Inc.
321.80
-1.62%
ALNY Alnylam Pharmaceuticals, Inc.
248.62
-5.16%
CTXR Citius Pharmaceuticals, Inc.
0.9749
-5.35%
PTIX Protagenic Therapeutics, Inc.
0.3740
-10.53%
BEAM Beam Therapeutics Inc.
15.43
-6.26%
HUMA Humacyte, Inc.
1.3800
-4.83%